# Ultragenyx Pharmaceutical Inc.: insider transactions

SEC CIK 1515673. Roles and transactions as reported on Form 4. Latest Form 4 filed 2021-08-12.

## Roles

| Company | Role | Transactions | First | Latest |
| --- | --- | ---: | --- | --- |
| [Arcturus Therapeutics Holdings Inc.](/companies/arct.md) | Director | 2 | 2021-08-10 | 2021-08-11 |
| [Arcturus Therapeutics Holdings Inc.](/companies/arct.md) | Director, 10% owner | 4 | 2020-05-20 | 2020-12-09 |

## Transactions: 6

Every transaction reported, newest first. Codes P and S are open-market purchases and sales. Reported price is as stated on the form.

| Date | Company | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | ---: | ---: | ---: | --- |
| 2021-08-11 | [Arcturus Therapeutics Holdings Inc.](/companies/arct.md) | Sale (S) | 75,000 | $45.83 | $3.4m | [Form 4](/filings/0001209191-21-051182.md) |
| 2021-08-10 | [Arcturus Therapeutics Holdings Inc.](/companies/arct.md) | Sale (S) | 725,000 | $55.44 | $40.2m | [Form 4](/filings/0001209191-21-051182.md) |
| 2020-12-09 | [Arcturus Therapeutics Holdings Inc.](/companies/arct.md) | Sale (S) | 357,745 | $94.97 | $34.0m | [Form 4](/filings/0001209191-20-062733.md) |
| 2020-12-08 | [Arcturus Therapeutics Holdings Inc.](/companies/arct.md) | Sale (S) | 442,255 | $105.54 | $46.7m | [Form 4](/filings/0001209191-20-062733.md) |
| 2020-05-20 | [Arcturus Therapeutics Holdings Inc.](/companies/arct.md) | Option exercise (M), derivative | 600,000 | $0.00 | $0 | [Form 4](/filings/0001209191-20-031641.md) |
| 2020-05-20 | [Arcturus Therapeutics Holdings Inc.](/companies/arct.md) | Option exercise (M) | 600,000 | $16.00 | $9.6m | [Form 4](/filings/0001209191-20-031641.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Nov 1, 2026, 23:41 ET. No prices; not investment advice.